Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Prescription volumes have surged, with GLP-1 users rising from 745 per 100,000 individuals in 2018 to 3,572 per 100,000 in 2023, indicating a 4.7x increase in adoption
Fiber-rich foods: Think berries, leafy greens, legumes, whole grains
Psychiatric adverse events linked to glucagon-like peptide 1 analogues: a disproportionality analysis in American, Canadian and Australian adverse event databases
While research into predictors of response is ongoing, there is currently insufficient evidence to recommend routine genetic testing to predict individual responses to semaglutide therapy
For weight management, inadequate response (less than 5% weight loss after several months at maintenance dose) may warrant reassessment of the treatment approach
